Ashland Global vs PPG Industries: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Ashland Global Holdings Inc (ASH)

Q3 202628 Jul – 25 Sep 2026

▲3

Ashland's sale process advances as buyback and new product offset weak additives

Takeover bids now being collected Ashland is collecting takeover bids this month, with Apollo, Carlyle and others interested. Activist pressure has pushed the company toward a possible sale, and reports suggest a deal could value shares well above recent levels. This keeps a buyout premium in the stock.
The sale process is the biggest force behind ASH's price right now, directly tied to activist pressure and reported bid interest.
New $1 billion buyback doubles prior plan Ashland announced a new $1 billion share repurchase plan, twice its previous authorization. Buying back stock can support the share price by reducing the number of shares and signaling management's confidence, even as the stock had slipped recently.
The buyback is a fresh capital-return action that directly supports the stock price and shows management's response to recent weakness.
New oral biologics ingredient launched Ashland launched Permexa sodium caprate, an ingredient that helps turn injectable drugs into pills, targeting the fast-growing GLP-1 and metabolic markets. Partners are already testing it. If it wins commercial contracts, it could add a new long-term growth stream.
This is a new product that could drive future revenue growth in Ashland's strongest division, Life Sciences.
Solid sales but profit pressure persists Third-quarter sales rose 7% to $497 million and full-year guidance was reaffirmed, but adjusted EBITDA fell 4% and EPS growth outlook was trimmed due to higher taxes and costs. Weak Specialty Additives and Intermediates continue to weigh on overall profitability.
This explains the underlying business performance that both supports and limits the stock, balancing the positive sale and buyback news.

August 202628 Jul – 25 Sep 2026

▲3

Ashland's sale process advances as buyback and new product offset weak additives

Takeover bids now being collected Ashland is collecting takeover bids this month, with Apollo, Carlyle and others interested. Activist pressure has pushed the company toward a possible sale, and reports suggest a deal could value shares well above recent levels. This keeps a buyout premium in the stock.
The sale process is the biggest force behind ASH's price right now, directly tied to activist pressure and reported bid interest.
New $1 billion buyback doubles prior plan Ashland announced a new $1 billion share repurchase plan, twice its previous authorization. Buying back stock can support the share price by reducing the number of shares and signaling management's confidence, even as the stock had slipped recently.
The buyback is a fresh capital-return action that directly supports the stock price and shows management's response to recent weakness.
New oral biologics ingredient launched Ashland launched Permexa sodium caprate, an ingredient that helps turn injectable drugs into pills, targeting the fast-growing GLP-1 and metabolic markets. Partners are already testing it. If it wins commercial contracts, it could add a new long-term growth stream.
This is a new product that could drive future revenue growth in Ashland's strongest division, Life Sciences.
Solid sales but profit pressure persists Third-quarter sales rose 7% to $497 million and full-year guidance was reaffirmed, but adjusted EBITDA fell 4% and EPS growth outlook was trimmed due to higher taxes and costs. Weak Specialty Additives and Intermediates continue to weigh on overall profitability.
This explains the underlying business performance that both supports and limits the stock, balancing the positive sale and buyback news.

Latest28 Jul – 25 Sep 2026

▲3

Ashland's sale process advances as buyback and new product offset weak additives

Takeover bids now being collected Ashland is collecting takeover bids this month, with Apollo, Carlyle and others interested. Activist pressure has pushed the company toward a possible sale, and reports suggest a deal could value shares well above recent levels. This keeps a buyout premium in the stock.
The sale process is the biggest force behind ASH's price right now, directly tied to activist pressure and reported bid interest.
New $1 billion buyback doubles prior plan Ashland announced a new $1 billion share repurchase plan, twice its previous authorization. Buying back stock can support the share price by reducing the number of shares and signaling management's confidence, even as the stock had slipped recently.
The buyback is a fresh capital-return action that directly supports the stock price and shows management's response to recent weakness.
New oral biologics ingredient launched Ashland launched Permexa sodium caprate, an ingredient that helps turn injectable drugs into pills, targeting the fast-growing GLP-1 and metabolic markets. Partners are already testing it. If it wins commercial contracts, it could add a new long-term growth stream.
This is a new product that could drive future revenue growth in Ashland's strongest division, Life Sciences.
Solid sales but profit pressure persists Third-quarter sales rose 7% to $497 million and full-year guidance was reaffirmed, but adjusted EBITDA fell 4% and EPS growth outlook was trimmed due to higher taxes and costs. Weak Specialty Additives and Intermediates continue to weigh on overall profitability.
This explains the underlying business performance that both supports and limits the stock, balancing the positive sale and buyback news.

PPG Industries Inc (PPG)

Q3 202615 Jul – 8 Oct 2026

▲4

PPG's aerospace and marine product launches, dividend raise, and $70M expansion drive growth

New digital tool for aircraft painting PPG launched AEROVIEW, a web-based virtual aircraft painter that lets customers customize paint colors in real time. This reduces costly repaint errors and speeds approvals, strengthening PPG's aerospace coatings business and supporting future sales growth.
Shows innovation that can boost aerospace coatings demand and customer loyalty.
Dividend increase signals confidence PPG raised its quarterly dividend to 74 cents per share, marking 54 straight years of increases. This reflects a strong balance sheet and cash flow, which can attract income investors and support the stock price.
Dividend hike is a clear sign of financial health and management confidence.
Q2 earnings show organic growth PPG reported 4% organic sales growth in Q2 2026, with revenue up 7% to $4.5 billion. Although adjusted EPS slightly missed estimates, the company reaffirmed full-year guidance, showing resilience and pricing power.
Earnings reveal underlying business momentum and guidance reaffirmation.
Marine coatings launch and aerospace expansion PPG introduced ONE RANGE marine coatings and previewed a new application tool, while also investing $70 million to expand aerospace transparencies production. These moves broaden product offerings and increase capacity to meet growing demand.
New products and capacity investment support future revenue growth.

August 202615 Jul – 8 Oct 2026

▲4

PPG's aerospace and marine product launches, dividend raise, and $70M expansion drive growth

New digital tool for aircraft painting PPG launched AEROVIEW, a web-based virtual aircraft painter that lets customers customize paint colors in real time. This reduces costly repaint errors and speeds approvals, strengthening PPG's aerospace coatings business and supporting future sales growth.
Shows innovation that can boost aerospace coatings demand and customer loyalty.
Dividend increase signals confidence PPG raised its quarterly dividend to 74 cents per share, marking 54 straight years of increases. This reflects a strong balance sheet and cash flow, which can attract income investors and support the stock price.
Dividend hike is a clear sign of financial health and management confidence.
Q2 earnings show organic growth PPG reported 4% organic sales growth in Q2 2026, with revenue up 7% to $4.5 billion. Although adjusted EPS slightly missed estimates, the company reaffirmed full-year guidance, showing resilience and pricing power.
Earnings reveal underlying business momentum and guidance reaffirmation.
Marine coatings launch and aerospace expansion PPG introduced ONE RANGE marine coatings and previewed a new application tool, while also investing $70 million to expand aerospace transparencies production. These moves broaden product offerings and increase capacity to meet growing demand.
New products and capacity investment support future revenue growth.

Latest15 Jul – 8 Oct 2026

▲4

PPG's aerospace and marine product launches, dividend raise, and $70M expansion drive growth

New digital tool for aircraft painting PPG launched AEROVIEW, a web-based virtual aircraft painter that lets customers customize paint colors in real time. This reduces costly repaint errors and speeds approvals, strengthening PPG's aerospace coatings business and supporting future sales growth.
Shows innovation that can boost aerospace coatings demand and customer loyalty.
Dividend increase signals confidence PPG raised its quarterly dividend to 74 cents per share, marking 54 straight years of increases. This reflects a strong balance sheet and cash flow, which can attract income investors and support the stock price.
Dividend hike is a clear sign of financial health and management confidence.
Q2 earnings show organic growth PPG reported 4% organic sales growth in Q2 2026, with revenue up 7% to $4.5 billion. Although adjusted EPS slightly missed estimates, the company reaffirmed full-year guidance, showing resilience and pricing power.
Earnings reveal underlying business momentum and guidance reaffirmation.
Marine coatings launch and aerospace expansion PPG introduced ONE RANGE marine coatings and previewed a new application tool, while also investing $70 million to expand aerospace transparencies production. These moves broaden product offerings and increase capacity to meet growing demand.
New products and capacity investment support future revenue growth.